MicroRNA and Cervical Cancer

Journal of International Obstetrics and Gynecology ›› 2009, Vol. 36 ›› Issue (6): 440-442.

• 综述 • Previous Articles Next Articles

MicroRNA and Cervical Cancer

ZHANG Jia-rong;LI Shuang-di;WAN Xiao-ping

The First People’s Hospital Affiliated Shanghai Jiaotong University, Shanghai 200080, China（ZHANG Jia-rong, LI Shuang-di）；Shanghai International Peace Maternity and Child Health Hospital, Shanghai 200030, China（WAN Xiao-ping）

Received:1900-01-01 Revised:1900-01-01 Published:2009-12-15 Online:2009-12-15

Abstract

Abstract: Cervical cancer is one of the most common malignant tumors,which is caused primarily by high risk human papilloma virus infection. MicroRNAs are endogenous noncoding small RNAs, which take part in many processes including virus infection and tumorigenesis. Great concern has been raised regarding cancer-related microRNAs recently. In cervical cancer, several microRNAs（miR-21, -143, -146a, -199a, et al） have been found to be de-expressed. Here we discuss the role of microRNAs in the development and progression of cervical cancer.

Key words: MicroRNA, Cervical cancer, Human papilloma virus, Tumor

ZHANG Jia-rong;LI Shuang-di;WAN Xiao-ping. MicroRNA and Cervical Cancer[J]. Journal of International Obstetrics and Gynecology, 2009, 36(6): 440-442.

[1]	PAN Qi, FENG Tong-fu, JIN Jing, WU Ying, DU Xin. Laparoscopic Resection of Giant Mature Retroperitoneal Teratoma in An Adult: A Case Report [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 28-31.
[2]	ZHANG Ye, CHEN Qiao-yun, ZHAO Jia-yi, CHEN Lu, LIU Jian-rong. Progress in the Application of Nanoparticles in the Prevention and Treatment of Cervical Cancer [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 8-12.
[3]	ZHANG Wen, LIU Hui-qiang. The Role of SOCS1 and Exosomal MicroRNA in the Pathogenesis of Preeclampsia [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 94-98.
[4]	CHEN Xing-yu, WEI Ya-jing, LIANG Yan-chun. Advances in Uterine Leiomyosarcoma：Mapping Based on Genomics [J]. Journal of International Obstetrics and Gynecology, 2024, 51(6): 641-647.
[5]	CHEN Zhi-ru, DAI Lan. Research Progress of the Relationship between Chemoradiotherapy-Induced Tumor Cell Death and Tumor Repopulation [J]. Journal of International Obstetrics and Gynecology, 2024, 51(6): 648-653.
[6]	LI Dan-ning, WANG Xi-peng. Research Progress on Utilizing Single-Cell Sequencing Technology to Investigate Tumor Immune Microenvironment in Epithelial Ovarian Cancer [J]. Journal of International Obstetrics and Gynecology, 2024, 51(6): 654-658.
[7]	HUANG Mo-ya, ZHAO Ya-qian, HE Yin-fang. Progress in the Diagnosis and Treatment of Pregnancy Complicated by Krukenberg Tumor [J]. Journal of International Obstetrics and Gynecology, 2024, 51(5): 531-535.
[8]	ZHANG Jian-nan, GUO Xin, GUO Nan, NING Wen-ting, YU Hong-xin, SHANG Hai-xia. Application of Microfluidic Technology in Ovarian Cancer Disease Modeling, Drug Evaluation, and Precision Medicine [J]. Journal of International Obstetrics and Gynecology, 2024, 51(5): 560-565.
[9]	BAI Yao-jun, HU Xiao-hong, LI Hong-li, LIU Chang. Research Progress on Lymphocyte Activation Gene-3 in Gynecological Tumors [J]. Journal of International Obstetrics and Gynecology, 2024, 51(5): 566-571.
[10]	JIN Xiao-lei, XU Fei-xue. Five Cases of Diagnosis and Treatment of Ovarian Brenner Tumors [J]. Journal of International Obstetrics and Gynecology, 2024, 51(5): 578-583.
[11]	SU Hai-qi, LI Lei. Advances in Methylation Detection for Ovarian Cancer Screening and Diagnosis [J]. Journal of International Obstetrics and Gynecology, 2024, 51(4): 366-369.
[12]	ZHANG Jing-yi, LIU Dong-zhe, CHEN Xiu-hui. Research Advances of Exosomes in Angiogenesis of Ovarian Cancer [J]. Journal of International Obstetrics and Gynecology, 2024, 51(4): 370-374.
[13]	ZHANG Ting-ting, YU Ping-yuan, CHEN Xi, ZHENG Duo, YANG Yong-xiu. A Case Report of Primary Ovarian Carcinoid with Liver Metastases [J]. Journal of International Obstetrics and Gynecology, 2024, 51(4): 380-383.
[14]	ZHANG Lan-yue, SHEN Fu-jin. Research Progress of Adoptive Cell Immunotherapy in Cervical Cancer [J]. Journal of International Obstetrics and Gynecology, 2024, 51(3): 253-257.
[15]	GUO Shi-wei, SUN Jing-li, CHEN Zhen-yu, LIU Sen. Clinical Application of Stem Cell-Derived Exosomes in Gynecological Diseases [J]. Journal of International Obstetrics and Gynecology, 2024, 51(3): 279-283.

MicroRNA and Cervical Cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments